首页 > 最新文献

Drug and alcohol review最新文献

英文 中文
Alcohol control policy and alcohol-attributable disease burden in Finland and the Baltic countries: A longitudinal study 1995–2019 芬兰和波罗的海国家的酒精控制政策与酒精所致疾病负担:1995-2019 年纵向研究。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-15 DOI: 10.1111/dar.13901
Anastasia Månsson, Lode van der Velde, Thomas Karlsson, Lauri Beekmann, Elsa Jonsson Stenberg, Juanita Haagsma, Giulio Castelpietra, Emilie E. Agardh, Peter Allebeck

Introduction

Alcohol remains a significant contributor to mortality and morbidity in Finland and the Baltic countries, particularly among men. This study aimed to assess alcohol policy restrictiveness in this region from 1995 to 2019 using a modified version of the Bridging the Gap (BtG-M) policy scale and examine its association with alcohol-related disease burden.

Methods

The study utilised national laws to score policy restrictiveness (higher BtG-M scores mean stricter policies) and age-standardised rates of disability-adjusted life years (DALY), years of life lost, years lived with disability and deaths per 100,000 from the 2019 Global Burden of Disease Study (GBD). Spearman correlation tests and panel data regression models were applied to assess the association between policy score and burden of disease.

Results

Finland maintained a high BtG-M score, while the Baltic countries experienced recent increases from initially lower scores. Alcohol-related disease burden showed an inverse association with policy changes in these countries. Strongest association was seen between the BtG-M score and DALY rates attributed to injuries. Premature mortality among men constituted the largest proportion of disease burden.

Discussion and Conclusions

Despite challenges in accessing and comparing policy data over time, we showed a strong association between alcohol policy and alcohol-related harm in Finland and the Baltic countries. This study is one of the first to use the BtG-M scale to monitor changes in alcohol policies over time and their relationship to alcohol-related harm using GBD methodology. The study highlights the effects of national alcohol policies on levels of alcohol-related harm.

导言:在芬兰和波罗的海国家,酒精仍然是导致死亡和发病的重要因素,尤其是在男性中。本研究旨在使用 "缩小差距"(BtG-M)政策量表的修订版评估该地区 1995 年至 2019 年的酒精政策限制性,并研究其与酒精相关疾病负担的关系:研究利用国家法律对政策限制性进行评分(BtG-M 评分越高,表示政策越严格),并利用《2019 年全球疾病负担研究》(GBD)中每 10 万人的残疾调整生命年(DALY)、丧失生命年数、残疾生存年数和死亡人数的年龄标准化比率。斯皮尔曼相关检验和面板数据回归模型用于评估政策得分与疾病负担之间的关联:结果:芬兰保持了较高的 BtG-M 分数,而波罗的海国家则从最初的较低分数上升到最近的较高分数。在这些国家,与酒精相关的疾病负担与政策变化呈反向关系。BtG-M 分数与因伤害造成的残疾调整寿命年数之间的关系最为密切。男性过早死亡在疾病负担中所占比例最大:尽管在获取和比较不同时期的政策数据方面存在挑战,但我们发现芬兰和波罗的海国家的酒精政策与酒精相关伤害之间存在密切联系。这项研究是首批使用 BtG-M 量表监测酒精政策随时间推移的变化及其与酒精相关危害之间关系的研究之一。该研究强调了国家酒精政策对酒精相关危害水平的影响。
{"title":"Alcohol control policy and alcohol-attributable disease burden in Finland and the Baltic countries: A longitudinal study 1995–2019","authors":"Anastasia Månsson,&nbsp;Lode van der Velde,&nbsp;Thomas Karlsson,&nbsp;Lauri Beekmann,&nbsp;Elsa Jonsson Stenberg,&nbsp;Juanita Haagsma,&nbsp;Giulio Castelpietra,&nbsp;Emilie E. Agardh,&nbsp;Peter Allebeck","doi":"10.1111/dar.13901","DOIUrl":"10.1111/dar.13901","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Alcohol remains a significant contributor to mortality and morbidity in Finland and the Baltic countries, particularly among men. This study aimed to assess alcohol policy restrictiveness in this region from 1995 to 2019 using a modified version of the Bridging the Gap (BtG-M) policy scale and examine its association with alcohol-related disease burden.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The study utilised national laws to score policy restrictiveness (higher BtG-M scores mean stricter policies) and age-standardised rates of disability-adjusted life years (DALY), years of life lost, years lived with disability and deaths per 100,000 from the 2019 Global Burden of Disease Study (GBD). Spearman correlation tests and panel data regression models were applied to assess the association between policy score and burden of disease.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Finland maintained a high BtG-M score, while the Baltic countries experienced recent increases from initially lower scores. Alcohol-related disease burden showed an inverse association with policy changes in these countries. Strongest association was seen between the BtG-M score and DALY rates attributed to injuries. Premature mortality among men constituted the largest proportion of disease burden.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Despite challenges in accessing and comparing policy data over time, we showed a strong association between alcohol policy and alcohol-related harm in Finland and the Baltic countries. This study is one of the first to use the BtG-M scale to monitor changes in alcohol policies over time and their relationship to alcohol-related harm using GBD methodology. The study highlights the effects of national alcohol policies on levels of alcohol-related harm.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 6","pages":"1338-1348"},"PeriodicalIF":3.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13901","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accessing supports due to others' harmful drinking 因他人有害饮酒而获得支持。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-15 DOI: 10.1111/dar.13898
Jade Rintala, Koen Smit, Robin Room, Heng Jiang, Anne-Marie Laslett

Introduction

Alcohol's harm to others (AHTO) refers to harms caused to those other than the drinker. The current paper estimates the prevalence of formal and informal supports sought due to AHTO and examines whether the type of support accessed varies by sociodemographic, economic and harm-related characteristics.

Methods

An Australian sample of 2574 people completed the 2021 AHTO survey, out of which 888 perceived they experienced harm from another's drinking. Prevalence of accessing services and supports was measured. Additionally, several sociodemographic factors, economic factors and harm-related factors were included in multivariable logistic regression models predicting service/support use. Specifically, four models were constructed probing use of any service/support, use of police, use of counselling services and use of family/friend support.

Results

Of the survey sample, 12.4% accessed any support/service. Seeking support from family and/or friends was most common, followed by police, counselling, healthcare services and being admitted to hospital. Women had higher odds of accessing counselling and family/friend support. Respondents with a higher education level and two or more financial stressors had higher odds of accessing police and counselling. Respondents harmed by a stranger had higher odds of accessing police, whereas respondents harmed by someone they know had higher odds of seeking support from family/friends. Experiencing more severe harm was associated with greater odds of accessing any support.

Discussion and Conclusions

Several sociodemographic and economic factors were associated with accessing different supports. These findings may inform service development, interventions and policy changes for people affected by others' drinking.

导言:酒精对他人的伤害(AHTO)是指对饮酒者以外的其他人造成的伤害。本文估算了因酒精对他人造成的伤害而寻求正式和非正式支持的普遍程度,并研究了获得支持的类型是否因社会人口、经济和伤害相关特征而有所不同:澳大利亚有 2574 人完成了 2021 年澳大利亚酗酒者健康状况调查,其中 888 人认为自己受到了他人酗酒的伤害。调查测量了获得服务和支持的普遍程度。此外,一些社会人口因素、经济因素和与伤害相关的因素也被纳入了预测服务/支持使用情况的多变量逻辑回归模型中。具体来说,我们构建了四个模型,分别探究任何服务/支持的使用情况、警方的使用情况、咨询服务的使用情况以及家庭/朋友支持的使用情况:在调查样本中,12.4%的人使用过任何支持/服务。向家人和/或朋友寻求支持最常见,其次是报警、咨询、医疗服务和入院。女性获得咨询和家人/朋友支持的几率更高。受教育程度较高且有两个或两个以上经济压力的受访者向警方求助和寻求咨询的几率较高。受到陌生人伤害的受访者向警方求助的几率更高,而受到熟人伤害的受访者向家人/朋友寻求支持的几率更高。受到更严重伤害的受访者寻求任何支持的几率更高:一些社会人口和经济因素与获得不同的支持有关。这些发现可以为受他人饮酒影响者的服务发展、干预措施和政策改变提供参考。
{"title":"Accessing supports due to others' harmful drinking","authors":"Jade Rintala,&nbsp;Koen Smit,&nbsp;Robin Room,&nbsp;Heng Jiang,&nbsp;Anne-Marie Laslett","doi":"10.1111/dar.13898","DOIUrl":"10.1111/dar.13898","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Alcohol's harm to others (AHTO) refers to harms caused to those other than the drinker. The current paper estimates the prevalence of formal and informal supports sought due to AHTO and examines whether the type of support accessed varies by sociodemographic, economic and harm-related characteristics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>An Australian sample of 2574 people completed the 2021 AHTO survey, out of which 888 perceived they experienced harm from another's drinking. Prevalence of accessing services and supports was measured. Additionally, several sociodemographic factors, economic factors and harm-related factors were included in multivariable logistic regression models predicting service/support use. Specifically, four models were constructed probing use of any service/support, use of police, use of counselling services and use of family/friend support.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the survey sample, 12.4% accessed any support/service. Seeking support from family and/or friends was most common, followed by police, counselling, healthcare services and being admitted to hospital. Women had higher odds of accessing counselling and family/friend support. Respondents with a higher education level and two or more financial stressors had higher odds of accessing police and counselling. Respondents harmed by a stranger had higher odds of accessing police, whereas respondents harmed by someone they know had higher odds of seeking support from family/friends. Experiencing more severe harm was associated with greater odds of accessing any support.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Several sociodemographic and economic factors were associated with accessing different supports. These findings may inform service development, interventions and policy changes for people affected by others' drinking.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 6","pages":"1493-1504"},"PeriodicalIF":3.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13898","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Young people's experiences of addiction to nicotine vaping products: A qualitative analysis from Aotearoa New Zealand 年轻人对尼古丁吸食产品上瘾的经历:来自新西兰奥特亚罗瓦的定性分析。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-15 DOI: 10.1111/dar.13902
Anna Graham-DeMello, Olivia Sloan, Katie Frost, Janet Hoek

Introduction

Young people who use nicotine-containing electronic cigarettes, or ‘vapes’, risk becoming addicted to these products. While several studies document dependency symptoms, few report in-depth qualitative analyses of addiction.

Methods

We explored experiences of self-reported vaping addiction using in-depth interviews with 22 young people aged 16–20 years who vaped and lived in Aotearoa New Zealand. Our semi-structured interview guide probed participants' early experiences and how they progressed from experimentation to addiction and explored how addiction affected their perceptions and daily routines. We used an inductive reflexive thematic analysis approach to interpret the data.

Results

Vaping's pervasiveness piqued participants' curiosity and encouraged trial. Most transitioned from experimentation to addiction within a couple of months; while a minority described a slower progression, nearly all felt irritable, angry or uncomfortable if they had to delay vaping. Intense cravings disrupted school and work routines and dictated how they spent their time. Many deeply regretted vaping and some suffered shame and embarrassment. These participants saw vaping as a threat to the well-being of younger youth, which they tried to shield from addiction.

Discussion and Conclusions

We go beyond earlier studies by probing the burden vaping comes to represent, offering new insights into young people's everyday experiences of vaping addiction. In addition to informing health promotion campaigns, our findings could inform policy directions. Understanding the speed with which addiction can occur, its impact on daily life, and the considerable regret many felt could help inform a more strategic and sorely needed approach to reducing youth vaping.

导言:使用含尼古丁电子香烟或 "vapes "的年轻人有可能对这些产品上瘾。虽然有几项研究记录了依赖症状,但很少有报告对成瘾进行深入的定性分析:我们对 22 名居住在新西兰奥特亚罗瓦、年龄在 16-20 岁之间的吸食者进行了深入访谈,探讨了他们自我报告的吸食成瘾经历。我们的半结构式访谈指南探究了参与者的早期经历以及他们是如何从尝试发展到上瘾的,并探讨了上瘾是如何影响他们的观念和日常生活的。我们采用归纳式反思主题分析方法来解释数据:结果:吸食电子烟的普遍性激发了参与者的好奇心并鼓励他们尝试。大多数人在几个月内从尝试过渡到上瘾;少数人描述了一个缓慢的过程,但几乎所有人都感到烦躁、愤怒或不舒服,如果他们不得不推迟吸食。强烈的渴望打乱了他们的学习和工作计划,也决定了他们如何打发时间。许多人对吸烟深感后悔,有些人感到羞耻和尴尬。这些参与者将吸食电子烟视为对年轻一代福祉的威胁,他们试图保护年轻一代不染上毒瘾:我们超越了之前的研究,探究了吸烟带来的负担,为年轻人日常的吸烟成瘾经历提供了新的见解。除了为健康宣传活动提供信息外,我们的研究结果还可以为政策制定提供参考。了解上瘾发生的速度、上瘾对日常生活的影响以及许多人感到的巨大遗憾,有助于为减少青少年吸烟提供更具战略性且亟需的方法。
{"title":"Young people's experiences of addiction to nicotine vaping products: A qualitative analysis from Aotearoa New Zealand","authors":"Anna Graham-DeMello,&nbsp;Olivia Sloan,&nbsp;Katie Frost,&nbsp;Janet Hoek","doi":"10.1111/dar.13902","DOIUrl":"10.1111/dar.13902","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Young people who use nicotine-containing electronic cigarettes, or ‘vapes’, risk becoming addicted to these products. While several studies document dependency symptoms, few report in-depth qualitative analyses of addiction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We explored experiences of self-reported vaping addiction using in-depth interviews with 22 young people aged 16–20 years who vaped and lived in Aotearoa New Zealand. Our semi-structured interview guide probed participants' early experiences and how they progressed from experimentation to addiction and explored how addiction affected their perceptions and daily routines. We used an inductive reflexive thematic analysis approach to interpret the data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Vaping's pervasiveness piqued participants' curiosity and encouraged trial. Most transitioned from experimentation to addiction within a couple of months; while a minority described a slower progression, nearly all felt irritable, angry or uncomfortable if they had to delay vaping. Intense cravings disrupted school and work routines and dictated how they spent their time. Many deeply regretted vaping and some suffered shame and embarrassment. These participants saw vaping as a threat to the well-being of younger youth, which they tried to shield from addiction.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>We go beyond earlier studies by probing the burden vaping comes to represent, offering new insights into young people's everyday experiences of vaping addiction. In addition to informing health promotion campaigns, our findings could inform policy directions. Understanding the speed with which addiction can occur, its impact on daily life, and the considerable regret many felt could help inform a more strategic and sorely needed approach to reducing youth vaping.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 7","pages":"1710-1717"},"PeriodicalIF":3.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13902","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving assessment and management of suicide risk among people who inject drugs: A mixed methods study conducted at the Medically Supervised Injecting Centre, Sydney 改进对注射吸毒者自杀风险的评估和管理:在悉尼医疗监督注射中心开展的一项混合方法研究。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-09 DOI: 10.1111/dar.13900
Kate Hocknull, Brennan Geiger, Mark Bartlett, Samantha Colledge-Frisby, Fiona Shand, Carolyn A. Day, Marianne Jauncey, Amanda Roxburgh

Introduction

People who inject drugs are 13 times more likely to die by suicide than the general population. Guidelines for responding to risk in this population are limited. Harm reduction services attended by people who inject drugs require targeted strategies to address the complexities of suicide risk among this population.

Methods

Co-design, engaging health professionals and people with lived experience informed the study. Mixed methods were used to understand the experience of managing suicide risk among clients attending the Medically Supervised Injecting Centre (MSIC) in Sydney. A survey was administered to assess staff confidence in managing risk. Focus groups were conducted with health professionals and MSIC clients to explore experiences of suicide management, response and opportunities for improvement.

Results

Half (N = 17) the MSIC staff surveyed reported over 10 years' experience working with this population. Confidence in managing suicide risk was low. Three key themes emerged from focus groups (N = 17): (i) Autonomy and the need to involve clients in the assessment process; (ii) Trust between clients and health professionals, and transparency in decision-making; and (iii) System barriers, described by health professionals as inadequate referral pathways for clients in distress, and by clients as negative experiences of care, including involuntary admission and not receiving medication (e.g. methadone).

Discussion and Conclusions

Revised assessment guidelines and a tailored safety plan were developed. These resources are also suitable for other alcohol and other drug services. The challenge in managing suicide risk in harm reduction services is balancing duty of care with staff–client relationships and client engagement.

导言:注射吸毒者死于自杀的几率是普通人群的 13 倍。应对这一人群自杀风险的指南非常有限。有注射吸毒者参加的减低伤害服务需要有针对性的策略,以应对这一人群中复杂的自杀风险:方法:共同设计,让医疗专业人员和有生活经验的人参与到研究中来。研究采用了混合方法,以了解悉尼医疗监督注射中心(MSIC)服务对象在管理自杀风险方面的经验。我们进行了一项调查,以评估工作人员在管理风险方面的信心。与医护人员和悉尼医疗监管注射中心的客户进行了焦点小组讨论,以探讨自杀管理经验、应对措施和改进机会:接受调查的半数(N = 17)澳门医务人员信息中心工作人员表示,他们有超过 10 年的工作经验。对管理自杀风险的信心不足。焦点小组(17 人)提出了三个关键主题:(i) 自主性以及让患者参与评估过程的必要性;(ii) 患者与医护人员之间的信任,以及决策的透明度;(iii) 系统障碍,医护人员将其描述为转介陷入困境的患者的途径不足,而患者则将其描述为护理方面的负面经历,包括非自愿入院和未接受药物治疗(如美沙酮):讨论和结论:制定了经修订的评估指南和量身定制的安全计划。这些资源也适用于其他酒精和其他药物服务。在减低伤害服务中管理自杀风险的挑战在于平衡照顾责任、员工与客户的关系以及客户的参与。
{"title":"Improving assessment and management of suicide risk among people who inject drugs: A mixed methods study conducted at the Medically Supervised Injecting Centre, Sydney","authors":"Kate Hocknull,&nbsp;Brennan Geiger,&nbsp;Mark Bartlett,&nbsp;Samantha Colledge-Frisby,&nbsp;Fiona Shand,&nbsp;Carolyn A. Day,&nbsp;Marianne Jauncey,&nbsp;Amanda Roxburgh","doi":"10.1111/dar.13900","DOIUrl":"10.1111/dar.13900","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>People who inject drugs are 13 times more likely to die by suicide than the general population. Guidelines for responding to risk in this population are limited. Harm reduction services attended by people who inject drugs require targeted strategies to address the complexities of suicide risk among this population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Co-design, engaging health professionals and people with lived experience informed the study. Mixed methods were used to understand the experience of managing suicide risk among clients attending the Medically Supervised Injecting Centre (MSIC) in Sydney. A survey was administered to assess staff confidence in managing risk. Focus groups were conducted with health professionals and MSIC clients to explore experiences of suicide management, response and opportunities for improvement.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Half (<i>N</i> = 17) the MSIC staff surveyed reported over 10 years' experience working with this population. Confidence in managing suicide risk was low. Three key themes emerged from focus groups (<i>N</i> = 17): (i) <i>Autonomy</i> and the need to involve clients in the assessment process; (ii) <i>Trust</i> between clients and health professionals, and transparency in decision-making; and (iii) <i>System barriers</i>, described by health professionals as inadequate referral pathways for clients in distress, and by clients as negative experiences of care, including involuntary admission and not receiving medication (e.g. methadone).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Revised assessment guidelines and a tailored safety plan were developed. These resources are also suitable for other alcohol and other drug services. The challenge in managing suicide risk in harm reduction services is balancing duty of care with staff–client relationships and client engagement.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 6","pages":"1597-1606"},"PeriodicalIF":3.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13900","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harm from others' drinking among young adults in Taiwan: Predictors and deteriorating quality of life 台湾年轻人因他人饮酒而受到伤害:预测因素和生活质量的恶化。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-09 DOI: 10.1111/dar.13903
Ren-Hao Chen, Hsing-Yi Chang, Yi-Tien Hsu, Wei J. Chen, Chuan-Yu Chen

Introduction

This study aimed to investigate the prevalence of different forms of harm from others’ drinking (HFOD), predictors and the relationship with multi-dimensional quality of life among young adults in an emerging alcohol market in Asia—Taiwan.

Methods

Data were extracted from a 2018 household survey with national representativeness on substance use experiences. The analytic sample comprised 4901 participants aged 18–34. Eight items were used to measure HFOD experiences. Five-dimensional quality of life was assessed by the EQ-5D-5L. Multivariable regressions with complex survey analyses were performed to estimate the prevalence and risk association.

Results

Almost 4.2% of young adults experienced any form of HFOD; psychological harm occurred more prevalently than physical harm (3.7% and 1.5%, respectively). Those aged 25–29 and 30–34 had a two- to three-fold risk of HFOD compared with those aged 18–24. Both non-drunk drinking and drunk drinking were associated with an increased risk of psychological HFOD (adjusted odds ratio 2.36 and 5.89, respectively), whereas the risk of physical HFOD was related only to drunk drinking (adjusted odds ratio 7.8). Psychological HFOD victimisation emerged as the strongest predictor for deteriorated quality of life (adjusted b −0.14; 95% confidence interval −0.24, −0.04), especially in the dimensions of pain/discomfort and anxiety/depression. Among HFOD victims, only 33% sought help.

Discussion and Conclusions

The HFOD among young adults, commonly exhibited in psychological form, was linked with deteriorated quality of life; nonetheless, young HFOD victims are under-recognised. When devising interventions for alcohol harm, developmental perspectives should be integrated into policies implemented in healthcare and community settings.

导言:本研究旨在调查亚洲新兴酒类市场--台湾的年轻成年人中不同形式的他人饮酒伤害(HFOD)的发生率、预测因素以及与多维生活质量的关系:数据来自 2018 年一项具有全国代表性的关于药物使用经历的家庭调查。分析样本包括 4901 名 18-34 岁的参与者。八个项目用于测量高频饮酒经验。五维生活质量由 EQ-5D-5L 评估。通过复杂的调查分析进行多变量回归,以估算患病率和风险关联:结果:近 4.2% 的青壮年经历过任何形式的 HFOD;心理伤害的发生率高于身体伤害(分别为 3.7% 和 1.5%)。与 18-24 岁的年轻人相比,25-29 岁和 30-34 岁的年轻人发生高频饮酒的风险要高出两到三倍。非醉酒饮酒和醉酒饮酒都与心理上的高频伤害风险增加有关(调整后的几率比分别为 2.36 和 5.89),而身体上的高频伤害风险仅与醉酒饮酒有关(调整后的几率比为 7.8)。心理上的高频饮酒受害是生活质量恶化的最强预测因素(调整后的比值比为-0.14;95%置信区间为-0.24,-0.04),尤其是在疼痛/不适和焦虑/抑郁方面。在高频心律失常患者中,只有 33% 的人寻求过帮助:年轻成年人的高酒精中毒通常以心理形式表现出来,与生活质量的下降有关;然而,年轻的高酒精中毒受害者却未得到充分认识。在制定酒精伤害干预措施时,应将发展观点纳入医疗保健和社区环境中实施的政策。
{"title":"Harm from others' drinking among young adults in Taiwan: Predictors and deteriorating quality of life","authors":"Ren-Hao Chen,&nbsp;Hsing-Yi Chang,&nbsp;Yi-Tien Hsu,&nbsp;Wei J. Chen,&nbsp;Chuan-Yu Chen","doi":"10.1111/dar.13903","DOIUrl":"10.1111/dar.13903","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>This study aimed to investigate the prevalence of different forms of harm from others’ drinking (HFOD), predictors and the relationship with multi-dimensional quality of life among young adults in an emerging alcohol market in Asia—Taiwan.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data were extracted from a 2018 household survey with national representativeness on substance use experiences. The analytic sample comprised 4901 participants aged 18–34. Eight items were used to measure HFOD experiences. Five-dimensional quality of life was assessed by the EQ-5D-5L. Multivariable regressions with complex survey analyses were performed to estimate the prevalence and risk association.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Almost 4.2% of young adults experienced any form of HFOD; psychological harm occurred more prevalently than physical harm (3.7% and 1.5%, respectively). Those aged 25–29 and 30–34 had a two- to three-fold risk of HFOD compared with those aged 18–24. Both non-drunk drinking and drunk drinking were associated with an increased risk of psychological HFOD (adjusted odds ratio 2.36 and 5.89, respectively), whereas the risk of physical HFOD was related only to drunk drinking (adjusted odds ratio 7.8). Psychological HFOD victimisation emerged as the strongest predictor for deteriorated quality of life (adjusted <i>b</i> −0.14; 95% confidence interval −0.24, −0.04), especially in the dimensions of pain/discomfort and anxiety/depression. Among HFOD victims, only 33% sought help.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>The HFOD among young adults, commonly exhibited in psychological form, was linked with deteriorated quality of life; nonetheless, young HFOD victims are under-recognised. When devising interventions for alcohol harm, developmental perspectives should be integrated into policies implemented in healthcare and community settings.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 6","pages":"1483-1492"},"PeriodicalIF":3.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The health effects of non-prescribed anabolic–androgenic steroid use: Findings from The Performance and image-enhancing drugs UseRS' Health (PUSH) audit 非处方合成代谢雄性类固醇使用对健康的影响:性能和图像增强药物使用者健康(PUSH)审计结果。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-07 DOI: 10.1111/dar.13899
Matthew Dunn, Joshua Dawe, Beng Eu, Kevin Lee, Timothy Piatkowski, Mark Stoové

Introduction

To ascertain the adverse health outcomes experienced by those using prescribed testosterone and non-prescribed anabolic–androgenic steroids presenting to general practitioner (GP) clinics.

Methods

Retrospective clinical audit from nine GP clinics in major metropolitan areas across three Australian states. Data included demographic and individual characteristics (age, sexuality, body mass index, smoking status and HIV status); performance and image-enhancing drug use (type, reasons for use, patient-reported adverse effects); and blood biochemistry measurements (lipid profiles, liver function tests and red blood cell tests). Adverse health outcomes included evidence of polycythaemia, hypertension, liver abnormalities and hypercholesterolemia.

Results

Three hundred men were identified as either using prescribed testosterone (66%; n = 197) or non-prescribed anabolic–androgenic steroids (AAS) (34%; n = 103). Individuals in the prescribed group were more likely to be older (p < 0.001), gay or bisexual (p < 0.001) and living with diagnosed HIV (p < 0.001) compared to individuals in the non-prescribed group. Abnormal liver function, polycythemia and gynecomastia were the top three adverse events experienced. When adjusting for age, sexuality, HIV status and smoking status, those who used non-prescribed AAS were more likely to experience any adverse event (aPR = 1.28; 95% CI 1.01–1.60; p = 0.038), hypertension (aPR = 1.86; 95% CI 1.19–2.91; p = 0.006) and liver abnormalities (aPR = 1.51; 95% CI 1.04–2.20; p = 0.030) compared to those using prescribed testosterone.

Discussion and Conclusion

For GPs who have clients who may be using, or who they suspect of using, AAS, these findings highlight the importance of not only exploring a patient's history of the adverse effects they have experienced, but that measuring for these other conditions may provide a more accurate clinical picture.

简介:目的目的:确定在全科医生(GP)诊所就诊的使用处方睾酮和非处方合成代谢雄性类固醇的患者的不良健康后果:方法:对澳大利亚三个州主要都市地区的九家全科医生诊所进行回顾性临床审计。数据包括人口统计学特征和个人特征(年龄、性取向、体重指数、吸烟状况和 HIV 感染状况);使用性能和图像增强药物的情况(类型、使用原因、患者报告的不良反应);以及血液生化测量(血脂概况、肝功能检测和红细胞检测)。不良健康后果包括多发性红细胞血症、高血压、肝功能异常和高胆固醇血症:三百名男性被确定为使用处方睾酮(66%;n = 197)或非处方合成代谢雄性类固醇(AAS)(34%;n = 103)。处方组中的个体年龄更大(P 讨论和结论:对于那些可能正在使用或怀疑正在使用合成代谢雄性类固醇的客户的全科医生来说,这些研究结果强调了不仅要了解患者的不良反应史,而且要对这些其他情况进行测量,这样才能提供更准确的临床信息。
{"title":"The health effects of non-prescribed anabolic–androgenic steroid use: Findings from The Performance and image-enhancing drugs UseRS' Health (PUSH) audit","authors":"Matthew Dunn,&nbsp;Joshua Dawe,&nbsp;Beng Eu,&nbsp;Kevin Lee,&nbsp;Timothy Piatkowski,&nbsp;Mark Stoové","doi":"10.1111/dar.13899","DOIUrl":"10.1111/dar.13899","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>To ascertain the adverse health outcomes experienced by those using prescribed testosterone and non-prescribed anabolic–androgenic steroids presenting to general practitioner (GP) clinics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Retrospective clinical audit from nine GP clinics in major metropolitan areas across three Australian states. Data included demographic and individual characteristics (age, sexuality, body mass index, smoking status and HIV status); performance and image-enhancing drug use (type, reasons for use, patient-reported adverse effects); and blood biochemistry measurements (lipid profiles, liver function tests and red blood cell tests). Adverse health outcomes included evidence of polycythaemia, hypertension, liver abnormalities and hypercholesterolemia.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Three hundred men were identified as either using prescribed testosterone (66%; <i>n</i> = 197) or non-prescribed anabolic–androgenic steroids (AAS) (34%; <i>n</i> = 103). Individuals in the prescribed group were more likely to be older (<i>p</i> &lt; 0.001), gay or bisexual (<i>p</i> &lt; 0.001) and living with diagnosed HIV (<i>p</i> &lt; 0.001) compared to individuals in the non-prescribed group. Abnormal liver function, polycythemia and gynecomastia were the top three adverse events experienced. When adjusting for age, sexuality, HIV status and smoking status, those who used non-prescribed AAS were more likely to experience any adverse event (aPR = 1.28; 95% CI 1.01–1.60; <i>p</i> = 0.038), hypertension (aPR = 1.86; 95% CI 1.19–2.91; <i>p</i> = 0.006) and liver abnormalities (aPR = 1.51; 95% CI 1.04–2.20; <i>p</i> = 0.030) compared to those using prescribed testosterone.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusion</h3>\u0000 \u0000 <p>For GPs who have clients who may be using, or who they suspect of using, AAS, these findings highlight the importance of not only exploring a patient's history of the adverse effects they have experienced, but that measuring for these other conditions may provide a more accurate clinical picture.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 7","pages":"1967-1975"},"PeriodicalIF":3.0,"publicationDate":"2024-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13899","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-examining mandatory drug testing in Australian prisons 重新审视澳大利亚监狱中的强制毒品检测。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-07 DOI: 10.1111/dar.13894
Jocelyn Chan, Mark Stoové, Jon Cook, Thileepan Naren

Mandatory drug testing is commonly used in Australian prisons to detect and deter drug use. In this commentary, we review the limited evidence for mandatory drug testing programs, highlight potential harms associated with their implementation and provide recommendations for drug surveillance in prisons concordant with a harm minimisation framework.

澳大利亚监狱通常采用强制毒品测试来检测和阻止毒品使用。在这篇评论中,我们回顾了强制毒品检测计划的有限证据,强调了与实施该计划相关的潜在危害,并根据危害最小化框架为监狱毒品监控提供了建议。
{"title":"Re-examining mandatory drug testing in Australian prisons","authors":"Jocelyn Chan,&nbsp;Mark Stoové,&nbsp;Jon Cook,&nbsp;Thileepan Naren","doi":"10.1111/dar.13894","DOIUrl":"10.1111/dar.13894","url":null,"abstract":"<p>Mandatory drug testing is commonly used in Australian prisons to detect and deter drug use. In this commentary, we review the limited evidence for mandatory drug testing programs, highlight potential harms associated with their implementation and provide recommendations for drug surveillance in prisons concordant with a harm minimisation framework.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 7","pages":"1654-1656"},"PeriodicalIF":3.0,"publicationDate":"2024-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceived barriers to help-seeking for people who use crystal methamphetamine: Perspectives of people with lived experience, family members and health workers 冰毒使用者在寻求帮助时遇到的障碍:有生活经验者、家庭成员和卫生工作者的观点。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-04 DOI: 10.1111/dar.13897
Steph Kershaw, Matthew Sunderland, Anna Grager, Louise Birrell, Hannah Deen, Nicola C. Newton, Lexine A. Stapinski, Katrina E. Champion, Frances Kay-Lambkin, Maree Teesson, Cath Chapman

Introduction

Barriers to help-seeking for illicit drug use cross psychosocial (e.g., knowledge of where to seek help, attitudinal beliefs like being afraid of what people will think) and structural (e.g., service availability) domains. Along with people who use illicit drugs, it is important to consider the perspectives of other key groups who are often involved in the help-seeking and recovery process. This study aimed to examine the perceived barriers to help-seeking for people who use crystal methamphetamine (‘ice’) among key groups (people who use crystal methamphetamine, families and friends, health workers) as well as the general community.

Methods

A cross-sectional online survey open to all Australian residents (aged ≥18 years) was conducted November 2018–March 2019. Four key groups of interest were recruited to examine and compare perceived barriers to help-seeking for crystal methamphetamine use.

Results

Participants (n = 2108) included: people who use/have used crystal methamphetamine (n = 564, 39%), health workers (n = 288, 26.8%), affected family/friends (n = 434, 13.7%) and general community (n = 822, 20.6%). People who used crystal methamphetamine demonstrated increased odds of reporting attitudinal (OR 1.35; 1.02–1.80) or structural (OR 1.89; 1.09–3.27) barriers, or a previous negative help-seeking experience (OR 2.27; 1.41–3.66) compared to knowledge barriers. Health workers demonstrated decreased odds of reporting attitudinal compared to knowledge barriers (OR 0.69; 0.50–0.95).

Discussion and Conclusions

Perceived barriers to seeking help for crystal methamphetamine use differed among key groups involved in treatment and recovery. Acknowledging and addressing the mismatches between key groups, through targeted interventions may better support people to seek help for crystal methamphetamine use.

导言:因使用非法药物而寻求帮助的障碍涉及社会心理(如对去哪里寻求帮助的了解、态度信念,如害怕别人的看法)和结构领域(如服务的可用性)。除了使用非法药物的人群,还必须考虑经常参与求助和康复过程的其他关键群体的观点。本研究旨在调查主要群体(冰毒使用者、家人和朋友、卫生工作者)以及普通社区对冰毒使用者寻求帮助时遇到的障碍的看法:2018年11月至2019年3月,开展了一项面向所有澳大利亚居民(年龄≥18岁)的横断面在线调查。调查招募了四个主要相关群体,以研究和比较他们对吸食冰毒寻求帮助的认知障碍:参与者(n = 2108)包括:吸食/曾吸食冰毒者(n = 564,39%)、卫生工作者(n = 288,26.8%)、受影响的家人/朋友(n = 434,13.7%)和普通社区(n = 822,20.6%)。与知识障碍相比,吸食冰毒者报告有态度障碍(OR 1.35;1.02-1.80)或结构障碍(OR 1.89;1.09-3.27)或以前有负面求助经历(OR 2.27;1.41-3.66)的几率增加。与知识障碍相比,医务工作者报告态度障碍的几率有所下降(OR 0.69;0.50-0.95):参与治疗和康复的主要群体对因吸食冰毒而寻求帮助时遇到的障碍的认识存在差异。通过有针对性的干预措施,承认并解决关键群体之间的不匹配问题,可以更好地支持人们就吸食冰毒寻求帮助。
{"title":"Perceived barriers to help-seeking for people who use crystal methamphetamine: Perspectives of people with lived experience, family members and health workers","authors":"Steph Kershaw,&nbsp;Matthew Sunderland,&nbsp;Anna Grager,&nbsp;Louise Birrell,&nbsp;Hannah Deen,&nbsp;Nicola C. Newton,&nbsp;Lexine A. Stapinski,&nbsp;Katrina E. Champion,&nbsp;Frances Kay-Lambkin,&nbsp;Maree Teesson,&nbsp;Cath Chapman","doi":"10.1111/dar.13897","DOIUrl":"10.1111/dar.13897","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Barriers to help-seeking for illicit drug use cross psychosocial (e.g., knowledge of where to seek help, attitudinal beliefs like being afraid of what people will think) and structural (e.g., service availability) domains. Along with people who use illicit drugs, it is important to consider the perspectives of other key groups who are often involved in the help-seeking and recovery process. This study aimed to examine the perceived barriers to help-seeking for people who use crystal methamphetamine (‘ice’) among key groups (people who use crystal methamphetamine, families and friends, health workers) as well as the general community.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A cross-sectional online survey open to all Australian residents (aged ≥18 years) was conducted November 2018–March 2019. Four key groups of interest were recruited to examine and compare perceived barriers to help-seeking for crystal methamphetamine use.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Participants (<i>n</i> = 2108) included: people who use/have used crystal methamphetamine (<i>n</i> = 564, 39%), health workers (<i>n</i> = 288, 26.8%), affected family/friends (<i>n</i> = 434, 13.7%) and general community (<i>n</i> = 822, 20.6%). People who used crystal methamphetamine demonstrated increased odds of reporting attitudinal (OR 1.35; 1.02–1.80) or structural (OR 1.89; 1.09–3.27) barriers, or a previous negative help-seeking experience (OR 2.27; 1.41–3.66) compared to knowledge barriers. Health workers demonstrated decreased odds of reporting attitudinal compared to knowledge barriers (OR 0.69; 0.50–0.95).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusions</h3>\u0000 \u0000 <p>Perceived barriers to seeking help for crystal methamphetamine use differed among key groups involved in treatment and recovery. Acknowledging and addressing the mismatches between key groups, through targeted interventions may better support people to seek help for crystal methamphetamine use.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 7","pages":"1929-1939"},"PeriodicalIF":3.0,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13897","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141533960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to ‘abstracts; paper 128’ 更正 "摘要;论文 128
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-04 DOI: 10.1111/dar.13887

Abstracts. Drug Alcohol Rev., 2023;42:S3–196. https://doi.org/10.1111/dar.13749

(Paper 128) The impact of imprisonment on hospitalisations with injecting-related injuries and diseases: A longitudinal cohort study.

There was an error in the dataset that generated the results for Paper 128. This error has been corrected and the findings and implications in the ‘Method’, ‘Results’, ‘Conclusion’ and ‘Implications for Policy’ sections have been updated as follows.

“Method: Data were drawn from 400 men participating in the Prison and Transition Health (PATH) study who injected drugs at least monthly prior to incarceration. Participants completed four surveys which were linked to state-wide hospital admissions and corrections data, 2014–2022. We estimated the crude incidence rate (per 1000 person-years) of hospitalisations for IRID overall and compared risk in and out of prison.

Results: Ninety-eight participants were admitted 181 times with an IRID diagnosis (13% of all hospitalisations). Most were for skin and soft tissue infections (73%) and 34% were for an invasive infection (admissions were not mutually exclusive). Overall IRID incidence rate was 59.2 (95% confidence interval [CI] 51.4–68.2) and 14.2 (95% CI 8.3–24.4) and 78.4 (95% CI 67.8–90.6) during time in and out of prison, respectively. There was a substantial reduction in risk of hospitalisation during time in prison (incidence rate ratio [IRR] 0.2; 95% CI 0.1–0.3; p < 0.001) compared to time in the community. This was similar for the risk of any invasive infections (IRR 0.1; 95% CI 0.0–0.3; p < 0.001) and skin and soft tissue infections (IRR 0.2; 95% CI 0.1–0.4; p < 0.001).

Conclusion: The incidence of hospitalisations with IRID among this cohort was high and appeared significantly elevated post-release.

Implications for Policy: These data evidence the desperate need for interventions that address injecting risk post-release.”

We apologise for this error.

摘要。Drug Alcohol Rev.,2023;42:S3-196。https://doi.org/10.1111/dar.13749(论文 128)监禁对注射相关伤害和疾病住院治疗的影响:一项纵向队列研究。生成论文 128 结果的数据集存在错误。这一错误已得到纠正,"方法"、"结果"、"结论 "和 "对政策的影响 "部分的结果和影响已更新如下:"方法:数据来自参与监狱与过渡时期健康(PATH)研究的 400 名男性,他们在入狱前至少每月注射一次毒品。参与者完成了四项调查,这些调查与 2014-2022 年全州的入院和惩教数据相关联。我们估算了IRID总体住院粗发病率(每千人年),并比较了监狱内外的风险:98 名参与者因 IRID 诊断入院 181 次(占住院总人数的 13%)。其中大部分是因为皮肤和软组织感染(73%),34%是因为侵入性感染(入院并不相互排斥)。在监狱内外期间,IRID 的总体发病率分别为 59.2(95% 置信区间 [CI] 51.4-68.2)、14.2(95% 置信区间 8.3-24.4)和 78.4(95% 置信区间 67.8-90.6)。与在社区服刑期间相比,在监狱服刑期间的住院风险大幅降低(发病率比 [IRR] 0.2; 95% CI 0.1-0.3; p < 0.001)。任何侵入性感染(IRR 0.1; 95% CI 0.0-0.3; p <0.001)以及皮肤和软组织感染(IRR 0.2; 95% CI 0.1-0.4; p <0.001)的风险与此类似:结论:在这批囚犯中,因 IRID 而住院的发生率很高,而且在释放后似乎明显升高:这些数据表明,迫切需要采取干预措施来解决释放后的注射风险问题。
{"title":"Correction to ‘abstracts; paper 128’","authors":"","doi":"10.1111/dar.13887","DOIUrl":"10.1111/dar.13887","url":null,"abstract":"<p>Abstracts. <i>Drug Alcohol Rev</i>., 2023;42:S3–196. https://doi.org/10.1111/dar.13749</p><p>(Paper 128) The impact of imprisonment on hospitalisations with injecting-related injuries and diseases: A longitudinal cohort study.</p><p>There was an error in the dataset that generated the results for Paper 128. This error has been corrected and the findings and implications in the ‘Method’, ‘Results’, ‘Conclusion’ and ‘Implications for Policy’ sections have been updated as follows.</p><p>“Method: Data were drawn from 400 men participating in the Prison and Transition Health (PATH) study who injected drugs at least monthly prior to incarceration. Participants completed four surveys which were linked to state-wide hospital admissions and corrections data, 2014–2022. We estimated the crude incidence rate (per 1000 person-years) of hospitalisations for IRID overall and compared risk in and out of prison.</p><p>Results: Ninety-eight participants were admitted 181 times with an IRID diagnosis (13% of all hospitalisations). Most were for skin and soft tissue infections (73%) and 34% were for an invasive infection (admissions were not mutually exclusive). Overall IRID incidence rate was 59.2 (95% confidence interval [CI] 51.4–68.2) and 14.2 (95% CI 8.3–24.4) and 78.4 (95% CI 67.8–90.6) during time in and out of prison, respectively. There was a substantial reduction in risk of hospitalisation during time in prison (incidence rate ratio [IRR] 0.2; 95% CI 0.1–0.3; <i>p</i> &lt; 0.001) compared to time in the community. This was similar for the risk of any invasive infections (IRR 0.1; 95% CI 0.0–0.3; <i>p</i> &lt; 0.001) and skin and soft tissue infections (IRR 0.2; 95% CI 0.1–0.4; <i>p</i> &lt; 0.001).</p><p>Conclusion: The incidence of hospitalisations with IRID among this cohort was high and appeared significantly elevated post-release.</p><p>Implications for Policy: These data evidence the desperate need for interventions that address injecting risk post-release.”</p><p>We apologise for this error.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 5","pages":"1325"},"PeriodicalIF":3.0,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13887","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141552819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 as a catalyst for alcohol policy change: A case study of the Gove Peninsula COVID-19 作为酒精政策变革的催化剂:戈夫半岛案例研究。
IF 3 3区 医学 Q2 SUBSTANCE ABUSE Pub Date : 2024-07-02 DOI: 10.1111/dar.13895
Sarah Clifford, Ian Crundall

In many ways, the COVID-19 pandemic provided a natural experiment for alternate ways of living and working. Although alcohol supply was one of many aspects impacted by COVID-19 restrictions, few of those alcohol-related measures have been continued. This commentary presents a unique case study from the Gove Peninsula in northern Australia, where pandemic restrictions acted as a catalyst for a review of an established alcohol management system. A permit system was introduced on the Gove Peninsula in 2008 to control who can purchase takeaway alcohol and how much they could buy each day. Development of the system was rooted in the principles of community development and self-determination. This commentary describes how COVID-19 and associated changes in levels of alcohol harms mobilised community support for a review of the system, that had operated unchanged for the past decade. COVID-19 was adventitious in revealing compelling localised information which encouraged examination of potential improvements to the system. An updated regime is now being trialled, which sets daily limits on the alcohol purchases of everyone in the area. This experience illustrates the benefits of timely and relevant data to assist communities in formulating local solutions to local problems.

在许多方面,COVID-19 大流行病为其他生活和工作方式提供了一个自然的实验。尽管酒精供应是受 COVID-19 限制措施影响的诸多方面之一,但与酒精相关的措施却很少得到延续。这篇评论介绍了澳大利亚北部戈夫半岛的一个独特案例研究,在那里,大流行病的限制措施成为了对既有酒类管理系统进行审查的催化剂。戈夫半岛于 2008 年引入许可证制度,以控制谁可以购买外卖酒以及每天可以购买多少。该制度的制定植根于社区发展和自决原则。本评论描述了 COVID-19 和酒精危害水平的相关变化如何动员社区支持对过去十年来一直未变的系统进行审查。COVID-19 的出现揭示了令人信服的本地化信息,鼓励人们对该系统的潜在改进进行研究。目前正在试行一种新的制度,该制度规定了该地区每个人每天的购酒限额。这一经验说明了及时提供相关数据的好处,可以帮助社区制定解决当地问题的办法。
{"title":"COVID-19 as a catalyst for alcohol policy change: A case study of the Gove Peninsula","authors":"Sarah Clifford,&nbsp;Ian Crundall","doi":"10.1111/dar.13895","DOIUrl":"10.1111/dar.13895","url":null,"abstract":"<p>In many ways, the COVID-19 pandemic provided a natural experiment for alternate ways of living and working. Although alcohol supply was one of many aspects impacted by COVID-19 restrictions, few of those alcohol-related measures have been continued. This commentary presents a unique case study from the Gove Peninsula in northern Australia, where pandemic restrictions acted as a catalyst for a review of an established alcohol management system. A permit system was introduced on the Gove Peninsula in 2008 to control who can purchase takeaway alcohol and how much they could buy each day. Development of the system was rooted in the principles of community development and self-determination. This commentary describes how COVID-19 and associated changes in levels of alcohol harms mobilised community support for a review of the system, that had operated unchanged for the past decade. COVID-19 was adventitious in revealing compelling localised information which encouraged examination of potential improvements to the system. An updated regime is now being trialled, which sets daily limits on the alcohol purchases of everyone in the area. This experience illustrates the benefits of timely and relevant data to assist communities in formulating local solutions to local problems.</p>","PeriodicalId":11318,"journal":{"name":"Drug and alcohol review","volume":"43 6","pages":"1445-1450"},"PeriodicalIF":3.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/dar.13895","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Drug and alcohol review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1